PR PolyResearch

Join Free

NASDAQ

Seaport Therapeutics, Inc. (SPTX)

♥ 521 Thanks from members

Seaport Therapeutics, Inc. (SPTX) trades around $24.03 with a consensus Buy/Hold rating and an average price target of $38, driven by its proprietary Glyph platform and lead Phase 2b asset SPT-300.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Other Nasdaq Tickers

GraniteShares 2x Long AAPL Daily ETF (AAPB)

Apple Inc. (AAPL)

Direxion Daily AAPL Bear 1X ETF (AAPD)

Ascentage Pharma Group International - American Depository Shares (AAPG)

Direxion Daily AAPL Bull 2X ETF (AAPU)

Rocket Pharmaceuticals, Inc. - Warrant (RCKTW)